115 related articles for article (PubMed ID: 11392620)
41. Structural analysis of muscarinic acetylcholine receptor type 1 intracellular loop 3 by hydrogen/deuterium exchange mass spectrometry.
Ko IY; Kim DK; Chung KY
Protein Pept Lett; 2015; 22(1):94-100. PubMed ID: 25311205
[TBL] [Abstract][Full Text] [Related]
42. Hydrophobic amino acids at the cytoplasmic ends of helices 3 and 6 of rhodopsin conjointly modulate transducin activation.
Bosch-Presegué L; Iarriccio L; Aguilà M; Toledo D; Ramon E; Cordomí A; Garriga P
Arch Biochem Biophys; 2011 Feb; 506(2):142-9. PubMed ID: 21114958
[TBL] [Abstract][Full Text] [Related]
43. Key amino acids located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor.
Derick S; Pena A; Durroux T; Wagnon J; Serradeil-Le Gal C; Hibert M; Rognan D; Guillon G
Mol Endocrinol; 2004 Nov; 18(11):2777-89. PubMed ID: 15284336
[TBL] [Abstract][Full Text] [Related]
44. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
Vogel WK; Sheehan DM; Schimerlik MI
Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
[TBL] [Abstract][Full Text] [Related]
45. Differential modulation of agonist potency and receptor coupling by mutations of Ser388Tyr and Thr389Pro at the junction of transmembrane domain VI and the third extracellular loop of human M(1) muscarinic acetylcholine receptors.
Huang XP; Williams FE; Peseckis SM; Messer WS
Mol Pharmacol; 1999 Oct; 56(4):775-83. PubMed ID: 10496961
[TBL] [Abstract][Full Text] [Related]
46. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
[TBL] [Abstract][Full Text] [Related]
47. Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between Cys316 and engineered cysteines in cytoplasmic loop 1.
Klein-Seetharaman J; Hwa J; Cai K; Altenbach C; Hubbell WL; Khorana HG
Biochemistry; 2001 Oct; 40(42):12472-8. PubMed ID: 11601970
[TBL] [Abstract][Full Text] [Related]
48. Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6.
Han M; Smith SO; Sakmar TP
Biochemistry; 1998 Jun; 37(22):8253-61. PubMed ID: 9609722
[TBL] [Abstract][Full Text] [Related]
49. Structure-function analysis of muscarinic acetylcholine receptors.
Kostenis E; Zeng FY; Wess J
J Physiol Paris; 1998; 92(3-4):265-8. PubMed ID: 9789820
[TBL] [Abstract][Full Text] [Related]
50. First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin.
Trabanino RJ; Hall SE; Vaidehi N; Floriano WB; Kam VW; Goddard WA
Biophys J; 2004 Apr; 86(4):1904-21. PubMed ID: 15041637
[TBL] [Abstract][Full Text] [Related]
51. Site-directed mutagenesis of m1-toxin1: two amino acids responsible for stable toxin binding to M(1) muscarinic receptors.
Krajewski JL; Dickerson IM; Potter LT
Mol Pharmacol; 2001 Oct; 60(4):725-31. PubMed ID: 11562434
[TBL] [Abstract][Full Text] [Related]
52. Structure-function studies of muscarinic acetylcholine receptors.
Leach K; Simms J; Sexton PM; Christopoulos A
Handb Exp Pharmacol; 2012; (208):29-48. PubMed ID: 22222693
[TBL] [Abstract][Full Text] [Related]
53. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
[TBL] [Abstract][Full Text] [Related]
54. Rhodopsin: structural basis of molecular physiology.
Menon ST; Han M; Sakmar TP
Physiol Rev; 2001 Oct; 81(4):1659-88. PubMed ID: 11581499
[TBL] [Abstract][Full Text] [Related]
55. Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors.
Cordomí A; Ismail S; Matsoukas MT; Escrieut C; Gherardi MJ; Pardo L; Fourmy D
Biochem Pharmacol; 2015 Aug; 96(3):237-46. PubMed ID: 26043830
[TBL] [Abstract][Full Text] [Related]
56. Elastic network normal mode dynamics reveal the GPCR activation mechanism.
Kolan D; Fonar G; Samson AO
Proteins; 2014 Apr; 82(4):579-86. PubMed ID: 24123518
[TBL] [Abstract][Full Text] [Related]
57. Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands.
Goodwin JA; Hulme EC; Langmead CJ; Tehan BG
Mol Pharmacol; 2007 Dec; 72(6):1484-96. PubMed ID: 17848601
[TBL] [Abstract][Full Text] [Related]
58. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.
Gnagey AL; Seidenberg M; Ellis J
Mol Pharmacol; 1999 Dec; 56(6):1245-53. PubMed ID: 10570052
[TBL] [Abstract][Full Text] [Related]
59. Location of agonist-dependent-phosphorylation sites in the third intracellular loop of muscarinic acetylcholine receptors (m2 subtype).
Nakata H; Kameyama K; Haga K; Haga T
Eur J Biochem; 1994 Feb; 220(1):29-36. PubMed ID: 8119296
[TBL] [Abstract][Full Text] [Related]
60. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
Huang XP; Ellis J
Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
